Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer

Norihito Soga,Hideaki Kise,Kiminobu Arima,Yoshiki Sugimura

Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer

2010

Norihito Soga
Hideaki Kise
Kiminobu Arima
Yoshiki Sugimura

Objective To evaluate the efficacy and toxicity of third-line gemcitabine monotherapy (Gem) in patients with platinum-resistant advanced urothelial cancer (UC).

Keywords:

Cancer research
General surgery
Cancer
Oncology
Gemcitabine
Internal medicine
Medicine
in patient
third line
urothelial cancer
platinum resistant
Toxicity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations